ArticleBone marrow transplantation2025

Post-transplant cyclophosphamide with post-engraftment anti-thymocyte globulin reduce moderate to severe chronic graft-versus-host disease in peripheral stem cell transplantation from HLA-matched unrelated and haploidentical donors.

Ying Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.